Actively Recruiting

Phase 3
Age: 18Years +
FEMALE
NCT05439005

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Led by Institut Curie · Updated on 2026-01-30

158

Participants Needed

3

Research Sites

234 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study will compare morphine consumption during the first 48 hours postoperatively between the OFA group and the CA control group.

CONDITIONS

Official Title

Opioid Free Versus Opioid Based Anaesthesia for Free Flap Reconstruction Surgery of the Breast: A Phase III Multicentric Randomized Controlled Study.

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Women aged 18 or older
  • Patients with French health insurance coverage (French social security number)
  • Eligible for free flap reconstruction surgery of the breast under general anesthesia
  • Provided written consent to participate
  • Negative blood pregnancy test for patients of childbearing age
Not Eligible

You will not qualify if you...

  • Allergy or intolerance to drugs such as dexmedetomidine, remifentanil, lidocaine, propofol, dexamethasone, ketamine, ketoprofen, nefopam, paracetamol, morphine, ropivacaine, droperidol, ondansetron
  • History of heart failure, arrhythmias, ischemic heart disease, or severe renal insufficiency
  • Pulse below 50 bpm during anesthesia consultation or beta blocker treatment
  • Treatment with ACE inhibitors or ARBs
  • Severe asthma
  • Symptomatic gastric or duodenal ulcer
  • Baseline systolic blood pressure below 100 mmHg
  • Chronic preoperative pain or use of WHO ladder step 2 or 3 analgesics preoperatively
  • Already included in another therapeutic trial evaluating an experimental molecule
  • Persons deprived of liberty or under guardianship
  • Difficulties assessing pain on a scale
  • Inability to undergo trial medical monitoring due to geographic, social, or psychological reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Institut Curie Paris

Paris, France, 75005

Actively Recruiting

2

Institut Curie Saint-Cloud

Saint-Cloud, France, 92210

Actively Recruiting

3

Gustave Roussy, Cancer Campus, Grand Paris

Villejuif, France

Actively Recruiting

Loading map...

Research Team

A

Anne-Claire COYNE, PhD

CONTACT

M

Mary SAAD, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here